ALEX vs BMRN · P/E 23, rev $236.6M vs P/E 40, rev $1.76B
Alexander & Baldwin Holdings Inc (ALEX) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Alexander & Baldwin Holdings Inc (ALEX) is a reit - retail company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ALEX revenue for 2024-12-31 was $236.6M. Net income was $60.5M. Revenue was up 13.3% from 2023-12-31 to 2024-12-31. ALEX currently screens at market cap $1.52B and trailing P/E 23.4.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ALEX currently screens at market cap $1.52B and trailing P/E 23.4. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ALEX and BMRN stock pages for the full models.
Not investment advice.